"Cardiovascular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
Descriptor ID |
D002317
|
MeSH Number(s) |
D27.505.954.411
|
Concept/Terms |
Cardiovascular Agents- Cardiovascular Agents
- Agents, Cardiovascular
- Cardiovascular Drugs
- Drugs, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Agents".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Agents".
This graph shows the total number of publications written about "Cardiovascular Agents" by people in this website by year, and whether "Cardiovascular Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 1 | 1 | 2 |
1999 | 0 | 1 | 1 |
2002 | 1 | 1 | 2 |
2003 | 0 | 1 | 1 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2007 | 4 | 1 | 5 |
2008 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 1 | 1 | 2 |
2012 | 4 | 1 | 5 |
2013 | 2 | 1 | 3 |
2014 | 0 | 2 | 2 |
2015 | 2 | 5 | 7 |
2016 | 5 | 3 | 8 |
2017 | 2 | 0 | 2 |
2018 | 6 | 1 | 7 |
2019 | 1 | 3 | 4 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Agents" by people in Profiles.
-
Select drug-drug interactions with colchicine and cardiovascular medications: A review. Am Heart J. 2022 10; 252:42-50.
-
gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema. Inflammation. 2022 Feb; 45(1):116-128.
-
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. JACC Cardiovasc Interv. 2019 12 23; 12(24):2515-2524.
-
A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease. Ann Vasc Surg. 2019 Nov; 61:91-99.e3.
-
Factors Associated with Delayed Transition to Oral Feeding in Infants with Single Ventricle Physiology. J Pediatr. 2019 08; 211:134-138.
-
Variation in care practices across pediatric acute care cardiology units: Results of the Pediatric Acute Care Cardiology Collaborative (PAC3 ) hospital survey. Congenit Heart Dis. 2019 May; 14(3):419-426.
-
2018 ACC/AHA/HRS guideline on the?evaluation and management of patients with bradycardia and cardiac conduction delay: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Heart Rhythm. 2019 09; 16(9):e227-e279.
-
2018 ACC/AHA/HRS guideline on the?evaluation and management of?patients with bradycardia and cardiac?conduction delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019 09; 16(9):e128-e226.
-
Planning and Conducting the ISCHEMIA Trial. Circulation. 2018 10 02; 138(14):1384-1386.
-
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018 Dec 15; 273:34-38.